Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: A prospective randomised clinical trial

European Urology

Volumn 58, Issue 2, 2010, Pages 185-190

  Divrik, Rauf Taner ^a   Ahin, Ali F ^a   Yildirim, Ümit ^a   Altok, Muammer ^a   Zorlu, Ferruh ^a  

^a Tepecik Training and Research Hospital   (Turkey)

Author keywords

Bladder cancer; Progression; Recurrence; Second TUR; Superficial transitional cell carcinoma; Urothelial carcinoma

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER MALFORMATION; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; DEATH; DISEASE COURSE; DISEASE FREE SURVIVAL; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SKIN TOXICITY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR VOLUME; URINE CYTOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; REOPERATION; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; URETHRA; URINARY BLADDER NEOPLASMS;

EID: 77955284667     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.03.007     Document Type: Article

References (20)

1. M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, and J. Palou-Redorta EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder Eur Urol 54 2008 303 314
2. T. Divrik, U. Yildirim, A. Eroglu, F. Zorlu, and H. Özen Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer? J Urol 175 2006 1258 1261
3. J. Rigaud, G. Karam, G. Braud, P. Glemain, J.M. Buzelin, and O. Bouchot Value of second endoscopic resection in stage T1 bladder tumors Prog Urol 12 2002 27 30
4. A. Brauers, R. Buettner, and G. Jakse Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? J Urol 165 2001 808 810
5. S.C. Dutta, J.A. Smith Jr., S.B. Shappell, C.S. Coffey, S.S. Chang, and M.S. Cookson Clinical understaging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy J Urol 166 2001 490 493
6. H.W. Herr The value of a second transurethral resection in evaluating patients with bladder tumors J Urol 162 1999 74 76
7. M.A. Zurkirchen, T. Sulser, A. Gaspert, and D. Hauri Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologist Urol Int 72 2004 99 102
8. R.T. Divrik, Ü. Yildirim, F. Zorlu, and H. Özen The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumours of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial J Urol 175 2006 1641 1644
9. J.N. Eble, G. Sauter, J.I. Epstein, World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs 2004 IARC Press Lyon, France
10. T.A. Vögeli, M.-O. Grimm, X. Simon, and R. Ackermann Prospective study to assess repeat transurethral resection in superficial bladder cancer Urologe A 41 2002 470 474
11. L. Schips, H. Augustin, and R.E. Zigeuner Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer? Urology 59 2002 220 223
12. G. Jakse, F. Algaba, P.-U. Malmström, and W. Oosterlinck A second-look TUR in T1 transitional cell carcinoma: why? Eur Urol 45 2004 539 546
13. M.C. Grimm, R. Ackermann, and T.A. Vogeli Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study J Urol 170 2003 433 437
14. R. Järvinen, E. Kaasinen, A. Sankila, and E. Rintala Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up Eur Urol 56 2009 260 265
15. R.J. Sylvester, A.P.M. van der Meijden, and W. Oosterlinck Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 2006 466 477
16. A.V. Bono, C. Benvenuti, G. Damiano, and J. Lovisolo Results of transurethral resection and intravesical doxorubicin prophylaxis in patients with T1G3 bladder cancer Urology 44 1994 329 334
17. M.S. Cookson, and M.F. Sarosdy Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy J Urol 148 1992 797
18. K. Gohji, M. Nomi, and M. Okamoto Conservative therapy for stage T1b, grade 3 transitional cell carcinoma of the bladder Urology 53 1999 308 313
19. R. Klan, U. Steiner, and T. Sauter Zystektomie beim schlecht differenzierten T1-Harnblasenkarzinom - oft zu früh? Akt Urol 29 1998 53
20. H.W. Herr A restaging transurethral resection of high risk superficial bladder cancer improves the initial response to BCG therapy J Urol 174 2005 2134 2137